rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Martin S. Brown Jr.

Director

Company insider

Files Form 4 as: Director, Cumberland Pharmaceuticals; Director, Brown Forman.

In numbers

Trades disclosed
38
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
25 May 2006
Last trade
18 Mar 2026
Last filed
20 Mar 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CPIX Cumberland PharmaceuticalsDirector · Biotechnology · last 18 Mar 20260 buys · 0 sells
Brown FormanDirector · last 14 Apr 20160 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
18 Mar 2026filed 20 Mar 2026CPIX Cumberland PharmaceuticalsBiotechnologySEC FORM 4 Code A$5,0401,800 at $2.80filing
18 Mar 2026filed 20 Mar 2026CPIX Cumberland PharmaceuticalsBiotechnologySEC FORM 4 Code A$5,0401,800 at $2.80filing
17 Mar 2025filed 18 Mar 2025CPIX Cumberland PharmaceuticalsBiotechnologySEC FORM 4 Code A$5,1701,000 at $5.17filing
25 Mar 2024filed 30 Jan 2025CPIX Cumberland PharmaceuticalsBiotechnologySEC FORM 4 Code A$4,2752,500 at $1.71filing
25 Mar 2024filed 26 Mar 2024CPIX Cumberland PharmaceuticalsBiotechnologySEC FORM 4 Code A$1,7101,000 at $1.71filing
24 Mar 2023filed 27 Mar 2023CPIX Cumberland PharmaceuticalsBiotechnologySEC FORM 4 Code A$1,9701,000 at $1.97filing
14 Apr 2016filed 15 Apr 2016Brown FormanSEC FORM 4 Code M$168K4,819 at $34.95filing
14 Apr 2016filed 15 Apr 2016Brown FormanSEC FORM 4 Code F$169K1,773 at $95.04filing
14 Apr 2016filed 15 Apr 2016Brown Formanoption or derivativeSEC FORM 4 Code M—4,819 at $0.00filing
4 Sep 2014filed 11 Mar 2015Brown FormanSEC FORM 4 Code G—100 at $0.00filing
29 Aug 2014filed 3 Sep 2014Brown FormanSEC FORM 4 Code M$28K761 at $36.40filing
29 Aug 2014filed 3 Sep 2014Brown FormanSEC FORM 4 Code F$28K303 at $91.52filing
29 Aug 2014filed 3 Sep 2014Brown Formanoption or derivativeSEC FORM 4 Code M—761 at $0.00filing
31 Dec 2012filed 14 Jan 2013Brown FormanSEC FORM 4 Code G—42,556 at $0.00filing
31 Dec 2012filed 14 Jan 2013Brown FormanSEC FORM 4 Code G—42,556 at $0.00filing
8 Jun 2012filed 17 May 2013Brown FormanSEC FORM 4 Code J—13,626filing
8 Jun 2012filed 12 Jun 2012Brown FormanSEC FORM 4 Code J—13,626filing
8 Jun 2012filed 12 Jun 2012Brown FormanSEC FORM 4 Code J—13,626filing
8 Jun 2012filed 12 Jun 2012Brown FormanSEC FORM 4 Code J—13,358filing
8 Jun 2012filed 12 Jun 2012Brown FormanSEC FORM 4 Code J—13,358filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

A. J. KazimiChairman and CEO · Chairman and CEO at Cumberland Pharmaceuticals, filing Form 4 there in the last year
James JonesDirector · Director at Cumberland Pharmaceuticals, filing Form 4 there in the last year
James L. HermanVP and Chief Compliance Office · VP and Chief Compliance Office at Cumberland Pharmaceuticals, filing Form 4 there in the last year
Joseph C. GalanteDirector · Director at Cumberland Pharmaceuticals, filing Form 4 there in the last year
Caroline YoungDirector · Director at Cumberland Pharmaceuticals, filing Form 4 there in the last year